Home » Topics » BioWorld Science

BioWorld Science
RSS

Serine/threonine-protein kinase Pim-1 inhibitors identified at Japan Tobacco

May 3, 2022

Lilly patents dopamine D1 receptor positive allosteric modulators

May 3, 2022

GlaxoSmithKline synthesizes new MRGPRX2 antagonists

May 3, 2022

Storm Therapeutics identifies new METTL3 inhibitors

May 3, 2022

New EGFR inhibitors discovered at the Dana-Farber Cancer Institute

May 3, 2022

OQL-051 shows prophylactic efficacy in models of chemotherapy-induced diarrhea

May 3, 2022

Bridge Biotherapeutics and Cyrus Therapeutics generate next-generation EGFR degraders

May 2, 2022

BioNova Pharmaceuticals menin inhibitor BNM-1192 shows promise for MLL rearranged leukemias

May 2, 2022

CF-370 shows synergy with amikacin in drug-resistant P. aeruginosa acute pneumonia model

May 2, 2022

Innate immune memory underlies inflammatory comorbidities: study

May 2, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...